MARKET

MNPR

MNPR

Monopar Therapeutics Inc
NASDAQ
111.12
+2.60
+2.40%
After Hours: 107.99 -3.13 -2.82% 17:35 07/17 EDT
OPEN
106.61
PREV CLOSE
108.52
HIGH
111.94
LOW
104.00
VOLUME
265.23K
TURNOVER
--
52 WEEK HIGH
112.57
52 WEEK LOW
29.18
MARKET CAP
744.40M
P/E (TTM)
-58.5273
1D
5D
1M
3M
1Y
5Y
1D
Monopar: A Rare Disease Asset With Heavy-Metal Upside (Initiating Buy)
Seeking Alpha · 1d ago
Weekly Report: what happened at MNPR last week (0706-0710)?
Weekly Report · 4d ago
Weekly Report: what happened at MNPR last week (0629-0703)?
Weekly Report · 07/06 10:30
Monopar Therapeutics: ALXN1840's Bull Case Has Improved
Seeking Alpha · 07/03 14:10
Monopar Therapeutics price target raised to $117 from $104 at BTIG
TipRanks · 07/01 11:00
Monopar Therapeutics director Nicole Sweeny files initial beneficial ownership statement
PUBT · 06/30 20:58
BUZZ-U.S. STOCKS ON THE MOVE-Chip stocks, Unicycive, Roblox
Reuters · 06/30 17:39
BUZZ-U.S. STOCKS ON THE MOVE-AMD, Roblox, Olin
Reuters · 06/30 15:44
More
About MNPR
Monopar Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company developing treatments for Wilson disease and novel radiopharmaceuticals for oncology. The Company’s product candidates are ALXN1840, MNPR-101, MNPR-101-Zr, MNPR-101-Lu, and MNPR-101-Ac. The Company’s Wilson disease product candidate is ALXN1840, a late-stage, investigational once-daily, oral medicine. Its radiopharmaceutical program consists of MNPR-101, a proprietary humanized monoclonal antibody that is being developed across multiple product candidates conjugated with different radioisotopes, for the treatment of advanced solid tumors. MNPR-101-Zr is the Company’s clinical-stage radiodiagnostic imaging agent comprised of MNPR-101 conjugated to zirconium-89. MNPR-101-Lu is its clinical-stage radiotherapeutic comprised of MNPR-101 conjugated to lutetium-177. MNPR-101-Ac is late-preclinical stage radiotherapeutic comprised of MNPR-101 conjugated to actinium-225.

Webull offers Monopar Therapeutics Inc stock information, including NASDAQ: MNPR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MNPR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MNPR stock methods without spending real money on the virtual paper trading platform.